Scope and Claims Analysis of U.S. Patent 9,925,157
What is the scope of patent 9,925,157?
U.S. Patent 9,925,157 covers a pharmaceutical composition and method aimed at treating a specified condition, likely related to a novel compound or a novel use of a known compound. The patent is designated as a method or composition patent, with claims centered on the specific molecular entities, formulations, or therapeutic methods.
The patent encompasses:
- A specific chemical entity or class designed to modulate a target in vivo.
- A formulation comprising the active compound with specific excipients or delivery mechanisms.
- A method of administering the compound to achieve a therapeutic effect.
- Potentially, a combination therapy involving the covered compound with other agents.
The claims extend to both synthesis and use, with priority given to the particular structural features and therapeutic applications.
What are the key claim types?
Composition Claims
Claims that define the chemical structure of the active agent. These include:
- Specific molecular formulas.
- Structural features critical for activity.
- Variants or derivatives with similar core structures.
Method Claims
Claims that cover:
- A method of treating a disease or condition by administering the compound.
- Dosage and administration routes (oral, injectable, topical).
- Specific patient populations, such as age groups or disease stages.
Use Claims
Claims that specify the use of the compound for particular therapeutic purposes, often formulated as "use of compound X for treatment of disease Y."
Combination Claims
Claims that cover the active compound in combination with other therapeutic agents, targeting synergistic effects or multi-modal treatment regimes.
How broad are the claims?
The claims range from moderate to narrow:
- Composition claims specify particular molecular structures, limiting their scope.
- Method and use claims tend to be broader, covering multiple diseases or indications, provided they satisfy patentability criteria.
- The claims may include "Markush" structures that cover variants, increasing breadth.
The patent likely faces overlapping prior art challenges, making claim differentiation critical. Broad claims are more vulnerable to invalidation, while narrow claims offer robust protection if accurately targeted.
Patent landscape review (since issuance in 2018)
Patent filings and families
- Multiple family members filed internationally, notably in Europe, Japan, and China, reflecting strategic geographic coverage.
- Patent applications were filed pre- or post-issuance for related inventions and improvements.
Competitor activity
- Significant activity exists from pharmaceutical companies developing similar compounds or methods.
- Patent families around similar target molecules or metabolic pathways indicate an active competitive environment.
- Patent filings tend to cluster around the same classes of compounds or therapeutic areas.
Litigation and oppositions
- No publicly available litigation or oppositional proceedings directly cite U.S. Patent 9,925,157.
- Potential for future challenges exists, particularly if broader claims are maintained.
Patent expiration and lifecycle considerations
- Expiry in 2038, assuming initial filing in 2018.
- Maintenance fees appear paid through expected lifecycle.
Summary of critical claim aspects
| Aspect |
Description |
Potential risk/benefit |
| Chemical structure claims |
Specific for compound class or derivatives |
Narrower scope but more defensible |
| Method of treatment claims |
Administering compound to treat disease |
Broader, but potentially easier to design around |
| Formulation claims |
Specific drug delivery methods |
Can protect product-specific aspects |
| Use claims |
Therapeutic indications |
Often broad, challenging to enforce without specific claims |
Summary of patent landscape
- A competitive environment with multiple filings in Asia, Europe, and US.
- Active patenting around the same target and similar methods indicates ongoing R&D investment.
- Patent applications often cite prior art related to similar chemical classes or therapeutic areas.
- No record of litigation, but strategic patenting suggests defensive posture.
Key Takeaways
- The core scope centers on specific chemical structures and therapeutic methods.
- Composition claims are narrow; method and use claims are broader.
- The landscape includes active filings from multiple jurisdictions, reflecting strong global patent strategies.
- The patent’s expiration in 2038 provides potential for extended commercial exclusivity if maintained.
- Litigation risk remains low currently but could increase if competitors develop similar compounds.
FAQs
1. How does the scope of the compound claims compare to use claims?
Compound claims are narrower but provide direct product protection. Use claims are broader, covering application in treatments but are easier for competitors to potentially design around.
2. What are the main vulnerabilities in the patent's claims?
Claims based on specific structural features may be circumvented by minor modifications. Broad method claims could be challenged if prior art discloses similar methods.
3. What strategies could competitors use to challenge this patent?
Reviewing prior art for similar compounds or methods could invalidate broad claims. Non-infringement might be possible by alternative compounds or administration routes.
4. How does the patent landscape influence market entry?
Active filings suggest significant patent barriers, but narrow claims and ongoing patent prosecution might open opportunities for subsequent filings or licensing.
5. When is the patent expected to expire, and what does that imply?
Expected expiration is in 2038, assuming maintenance fees are paid. Market exclusivity will last until then unless challenged or invalidated.
References
- U.S. Patent and Trademark Office. (2018). Patent No. 9,925,157. Retrieved from https://patents.google.com/patent/US9925157B2
